ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.
Storage: 2-8C
Application: Quality Control TestingEvaluated by Western Blotting in MCF-7 cell lysate.Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Calcitonin Gene-Related Peptide 1 (CGRP-1) in MCF-7 cell lysate.Tested ApplicationsWestern Blotting Analysis: A 1:1,000 dilution from a representative lot detected CGRP-1 in PC12 and K562 cells and in Human and mouse liver lysates.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected CGRP-1 in human cerebral cortex and human DRG tissue sections.Affinity Binding Assay: A representative lot of this antibody bound CGRP-1 peptide with a KD of 1.9 x 10-7 in an affinity binding assay.Immunocytochemistry Analysis: A 1:1,000 dilution from a representative lot detected CGRP-1 in MCF7 cells.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany